These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20607268)

  • 1. Mortality associated with Acinetobacter baumannii infections experienced by lung transplant recipients.
    Nunley DR; Bauldoff GS; Mangino JE; Pope-Harman AL
    Lung; 2010 Oct; 188(5):381-5. PubMed ID: 20607268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant Acinetobacter baumannii pneumonia in lung transplant recipients.
    Sopirala MM; Pope-Harman A; Nunley DR; Moffatt-Bruce S; Ross P; Martin SI
    J Heart Lung Transplant; 2008 Jul; 27(7):804-7. PubMed ID: 18582814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.
    Chaari A; Pham T; Mnif B; Chtara K; Medhioub F; Baccouche N; Bahloul M; Hammami A; Bouaziz M
    Intensive Care Med; 2015 Nov; 41(11):2018-9. PubMed ID: 26264246
    [No Abstract]   [Full Text] [Related]  

  • 4. Multidrug-resistant
    Oh DH; Kim YC; Kim EJ; Jung IY; Jeong SJ; Kim SY; Park MS; Kim A; Lee JG; Paik HC
    Infect Dis (Lond); 2019 Jul; 51(7):493-501. PubMed ID: 31081415
    [No Abstract]   [Full Text] [Related]  

  • 5. Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
    Choi IS; Lee YJ; Wi YM; Kwan BS; Jung KH; Hong WP; Kim JM
    Int J Antimicrob Agents; 2016 Aug; 48(2):175-80. PubMed ID: 27423416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
    Ku K; Pogue JM; Moshos J; Bheemreddy S; Wang Y; Bhargava A; Campbell M; Khandker N; Lephart PR; Chopra T; Hayakawa K; Martin ET; Abreu-Lanfranco O; Dhar S; Kaye KS; Marchaim D
    Am J Infect Control; 2012 Dec; 40(10):983-7. PubMed ID: 22440526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.
    Ricciardi R; Ricciardi AM; Danzi G
    Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
    Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
    Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
    J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is tigecyclin a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?
    Tasbakan MS; Pullukcu H; Sipahi OR; Tasbakan MI; Aydemir S; Bacakoglu F
    J Chemother; 2011 Dec; 23(6):345-9. PubMed ID: 22233818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.
    Parra Millán R; Jiménez Mejías ME; Sánchez Encinales V; Ayerbe Algaba R; Gutiérrez Valencia A; Pachón Ibáñez ME; Díaz C; Pérez Del Palacio J; López Cortés LF; Pachón J; Smani Y
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4464-70. PubMed ID: 27161639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
    Arroyo LA; Mateos I; González V; Aznar J
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
    Jean SS; Hsieh TC; Lee WS; Hsueh PR; Hsu CW; Lam C
    Medicine (Baltimore); 2018 Sep; 97(39):e12278. PubMed ID: 30278498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of Acinetobacter baumannii ventilator-associated pneumonia.
    Montero A; Corbella X; Ariza J
    Crit Care Med; 2003 Oct; 31(10):2557-9. PubMed ID: 14530770
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety profile comparison of colistin and tigecycline on the extensively drug resistant Acinetobacter baumannii.
    Kwon SH; Ahn HL; Han OY; La HO
    Biol Pharm Bull; 2014; 37(3):340-6. PubMed ID: 24583855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.